Predictors of Survival on Anti-TNF in an Observational Cohort of Patients with Ankylosing Spondylitis: The Role of MRI Parameters of Inflammation and Structural Damage

被引：0
|
作者：
Maksymowych, Walter [1 ]
Zhao, Zheng [2 ]
Wichuk, Stephanie [1 ]
Chiowchanwisawakit, Praveena [3 ]
Lambert, Robert G. [4 ]
Bernatsky, Sasha [5 ]
Conner-Spady, Barbara [1 ]
Spady, Donald [1 ]
Pedersen, Susanne Juhl [6 ]
机构：
[1] Univ Alberta, Med, Edmonton, AB, Canada
[2] Chinese Peoples Liberat Army Gen Hosp, Rheumatol, Beijing 100853, Peoples R China
[3] Mahidol Univ, Siriraj Hosp, Med, Rheumatol, Bangkok 10700, Thailand
[4] Univ Alberta, Radiol, Edmonton, AB, Canada
[5] McGill MUHC RVH, Rheum Clin Epid, Montreal, PQ, Canada
[6] Univ Copenhagen, Glostrup Hosp, Copenhagen Ctr Arthrit Res, Copenhagen, Denmark
来源：
ARTHRITIS & RHEUMATOLOGY | 2015年 / 67卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1747
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Observational study of switching anti-TNF agents in ankylosing spondylitis and psoriatic arthritis versus rheumatoid arthritis
    Haberhauer, Guenther
    Strehblow, Christoph
    Fasching, Peter
    WIENER MEDIZINISCHE WOCHENSCHRIFT, 2010, 160 (9-10) : 220 - 224
  • [42] International ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitis
    Braun, J
    Pham, T
    Sieper, J
    Davis, J
    van der Linden, S
    Dougados, M
    van der Heijde, D
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 55 - 55
  • [43] Does anti-TNF therapy decrease the incidence of anterior uveitis in patients with ankylosing spondylitis?
    Grace Levy-Clarke
    Robert Nussenblatt
    Nature Clinical Practice Rheumatology, 2006, 2 (2): : 72 - 73
  • [44] Monoclonal anti-TNF antibodies can elevate hemoglobin level in patients with ankylosing spondylitis
    Cemal Bes
    Ayten Yazici
    Mehmet Soy
    Rheumatology International, 2013, 33 : 1415 - 1418
  • [45] Anti-TNF treatment in ankylosing spondylitis patients with chronic kidney disease: Is it effective and safe?
    Coskun, Belkis Nihan
    Yagiz, Burcu
    Corabay, Seniha Gunduz
    Pehlivan, Yavuz
    Dalkilic, Ediz
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2022, 9 (02) : 68 - 74
  • [46] RISK OF HOSPITALIZED SERIOUS INFECTION IN SPONDYLITIS ANKYLOSING (AS) PATIENTS USING NBDMARD OR ANTI-TNF
    Moura, C. S.
    Rahme, E.
    Maksymowych, W. P.
    Abrahamowicz, M.
    Bessette, L.
    Bernatsky, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 266 - 267
  • [47] Monitoring patients with ankylosing spondylitis on anti-TNF monotherapy: too much too often?
    Gunasekera, W.
    Creamer, P.
    Creamer, K.
    Sengupta, R.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2017, 46 (04) : 330 - 331
  • [48] A Retrospective Analysis of Anti-TNF Treatment of 146 Ankylosing Spondylitis Patients According to Gender
    Yalcinkaya, Yasemin
    Pehlivan, Ozlem
    Omma, Ahmet
    Artim-Esen, Bahar
    Erer, Burak
    Huseyinsinoglu, Nihat
    Kamali, Sevil
    Inanc, Murat
    Aral, Orhan
    Gul, Ahmet
    Ocal, Lale
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S519 - S520
  • [49] Quality of life improvement in patients with severe ankylosing spondylitis upon treatment with anti-TNFα.
    Brandt, J
    Haibel, H
    Thriene, W
    Sieper, J
    Braun, J
    ARTHRITIS AND RHEUMATISM, 2000, 43 (09): : S403 - S403
  • [50] The Role of CRP and Peripheral Disease in Achieving ASDAS Response to Anti-TNF Therapy in 397 Patients with Ankylosing Spondylitis
    Fagerli, Karen Minde
    Lie, Elisabeth
    van der Heijde, D. M. F. M.
    Heiberg, Marte S.
    Rodevand, Erik
    Kaufmann, Cecillie
    Mikkelsen, Knut
    Kalstad, Synnove
    Kvien, Tore K.
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S203 - S204
12345